These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. Caso JA; Prieto Jde M; Casas E; Sanz J AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970 [No Abstract] [Full Text] [Related]
9. Switching from protease inhibitors to the non-nuke efavirenz. TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089 [No Abstract] [Full Text] [Related]
10. Four-drug regimens may be better. AIDS Patient Care STDS; 2000 Dec; 14(12):671. PubMed ID: 11119435 [No Abstract] [Full Text] [Related]
11. NNRTI hepatotoxicity: efavirenz versus nevirapine. Pulido F; Torralba M J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215 [No Abstract] [Full Text] [Related]
13. Hypersensitivity syndrome associated with efavirenz therapy. Bossi P; Colin D; Bricaire F; Caumes E Clin Infect Dis; 2000 Jan; 30(1):227-8. PubMed ID: 10619772 [No Abstract] [Full Text] [Related]
14. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]. van Leth F; Lange JM Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943 [TBL] [Abstract][Full Text] [Related]
15. [Valuable combination partner. Great benefit for therapy naive patients]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():82-4. PubMed ID: 15373061 [No Abstract] [Full Text] [Related]
16. Non-nucleoside reverse transcriptase inhibitors--an overview. Bell C; Matthews GV; Nelson MR Int J STD AIDS; 2003 Feb; 14(2):71-7. PubMed ID: 12662384 [No Abstract] [Full Text] [Related]
17. Reply. Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. Gonzalez A; Everall I AIDS; 1999 Oct; 13(14):1996. PubMed ID: 10513671 [No Abstract] [Full Text] [Related]
18. Myelomeningocele in a child with intrauterine exposure to efavirenz. Fundarò C; Genovese O; Rendeli C; Tamburrini E; Salvaggio E AIDS; 2002 Jan; 16(2):299-300. PubMed ID: 11807320 [No Abstract] [Full Text] [Related]
19. Factors affecting adherence and convenience in antiretroviral therapy. Lafeuillade A Int J STD AIDS; 2001 Nov; 12 Suppl 4():18-24. PubMed ID: 11589824 [No Abstract] [Full Text] [Related]